Innate and adaptive receptors interact to balance humoral immunity

Journal of Immunology

Volumn 184, Issue 5, 2010, Pages 2231-2232

  Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIBODY; COMPLEMENT COMPONENT C3D RECEPTOR; B LYMPHOCYTE ANTIGEN; CD19 ANTIGEN; MONOCLONAL ANTIBODY;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL EXPANSION; CELL PROLIFERATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; ANIMAL; CYTOLOGY; DNA REPLICATION; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; NOTE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD19; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL PROLIFERATION; DNA REPLICATION; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE;

EID: 77951900825     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1090001     Document Type: Review

References (21)

1. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256: 105-107.
2. Pezzutto, A., B. Dörken, P. S. Rabinovitch, J. A. Ledbetter, G. Moldenhauer, and E. A. Clark. 1987. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J. Immunol. 138: 2793-2799. (Pubitemid 17072750)
3. Uckun, F. M., W. Jaszcz, J. L. Ambrus, A. S. Fauci, K. Gajl-Peczalska, C. W. Song, M. R. Wick, D. E. Myers, K. Waddick, and J. A. Ledbetter. 1988. Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood 71: 13-29.
4. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149: 2841-2850.
5. Kansas, G. S., and T. F. Tedder. 1991. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol. 147: 4094-4102.
6. Carter, R. H., D. A. Tuveson, D. J. Park, S. G. Rhee, and D. T. Fearon. 1991. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J. Immunol. 147: 3663-3671.
7. 2+ responses: a role for Lyn sequestration in extinguishing negative regulation. J. Biol. Chem. 276: 44820-44827.
8. Depoil, D., S. Fleire, B. L. Treanor, M. Weber, N. E. Harwood, K. L. Marchbank, V. L. Tybulewicz, and F. D. Batista. 2008. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat. Immunol. 9: 63-72.
9. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173: 55-64.
10. van Noesel, C. J. M., A. C. Lankester, and R. A. W. van Lier. 1993. Dual antigen recognition by B cells. Immunol. Today 14: 8-11.
11. Dempsey, P. W., M. E. D. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271: 348-350.
12. Haas, K. M., F. R. Toapanta, J. A. Oliver, J. C. Poe, J. H. Weis, D.R. Karp, J. F.Bower, T.M. Ross, and T. F. Tedder. 2004. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J. Immunol. 172: 5833-5837.
13. Chakravarty, L., M. D. Zabel, J. J. Weis, and J. H. Weis. 2002. Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation. Int. Immunol. 14: 139-146.
14. Lee, Y., K. M. Haas,D. O.Gor, X. Ding,D. R. Karp, N. S. Greenspan, J. C. Poe, and T. F. Tedder. 2005. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement. J. Immunol. 175: 8011-8023. (Pubitemid 41798363)
15. Tedder, T. F., J. C. Poe, M. Fujimoto, K. M. Haas, and S. Sato. 2005. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr. Dir. Autoimmun. 8: 55-90.
16. Fujimoto, M., Y. Fujimoto, J. C. Poe, P. J. Jansen, C. A. Lowell, A. L. DeFranco, and T. F. Tedder. 2000. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 13: 47-57.
17. Fujimoto, M.,A. P.Bradney, J.C. Poe,D.A. Steeber, and T. F. Tedder. 1999. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 11: 191-200.
18. Rickert, R. C. 2005 Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr. Opin. Immunol. 17: 237-243.
19. Hasegawa, M., M. Fujimoto, J. C. Poe, D. A. Steeber, and T. F. Tedder. 2001. CD19 can regulate B lymphocyte signal transduction independent of complement activation. J. Immunol. 167: 3190-3200. (Pubitemid 32852558)
20. Haas, K. M., M. Hasegawa, D. A. Steeber, J. C. Poe, M. D. Zabel, C. B. Bock, D. R. Karp, D. E. Briles, J. H. Weis, and T. F. Tedder. 2002. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17: 713-723.
21. Haas, K. M., J. C. Poe, and T. F. Tedder. 2009. CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression. J. Immunol. 183: 3661-3671.